ASX 300

Growth investing boils down to investing in businesses that initiate, drive, and enact change in their respective markets. Regardless of the macro environment,...

Spartan and Astral among those attracting attention; Plus, Boss chief says uranium price has to rise much further to encourage new supply.

The daily Match Out for Thursday, 21 September 2023 with James Gerrish of Market Matters

For real estate investment trusts (REITs) at home and abroad, last financial year was tough. With inflation charging and interest rates in hot pursuit, for the first...

Don't be fooled. Fixed income can also earn you an equity-like return.

The final months of the year can set up a positive new year for share markets, but will cost-of-living pressures create a bloodbath?

Let's put market efficiency to the test by selecting 5 ASX 200 stocks at random and see if their intrinsic value approximates market price.

The daily Match Out for Wednesday, 20 September 2023 with James Gerrish of Market Matters

What's new about a delay for Qantas? Everything when you get to the short term bonus.

Key insights from the latest QVG Capital webinar, featuring Tony Waters, Chris Prunty and Josh Clark.

Retail - even when the going gets tough, there’s still opportunities to be found

Rate rises and cuts don’t have a clear-cut universal impact on property investments. The market has under-estimated this in the past.

Analyst target price revisions show optimism towards health care & technology, and pessimism towards energy & telecommunications.

Goodman's co-founder and its Deputy Group CEO have sold a collective $31 million worth of shares since late August.

It’s no secret that small caps have struggled in recent times, but the coming environment could suit them.

Perpetual’s deputy head of equities, Anthony Aboud, explains how to look for companies that are well suited to the current environment.

And is now focused on generating passive income through a variety of investments.

The daily Match Out for Monday 18 September with James Gerrish at Market Matters.

Crises in the Chinese property and shadow banking sector may have commentators concerned with good reason.

In the latest episode of the Invest it Best podcast, I speak with Wilsons Analyst (Healthcare), Dr Shane Storey, about investing in Medical Devices (MedTech). Dr Shane...

How we narrowed the All Ords down to 21 companies with an above-average yield, growing dividends and a price-to-earnings of less than 20.

This season, companies presented a mixed bag of financial results, reflecting the ongoing economic uncertainty fuelled by global challenges and domestic concerns.To...

Inspired by an article featuring billionaire stock picks, we ask Australia's most intelligent reader base to share their winning moves.

There's lots of hype around AI, but the team at Firetrail is finding the most compelling value in old-world assets with reliable cash flows.